Find a Top Oncologist Near Me – Book an Appointment Instantly

Carol Rapso,n MD, is a medical oncologist at Red Cedar Oncology in East Lansing and Charlotte, Michigan. 

Dr. Rapson earned her medical degree from Michigan State University and completed her residency and fellowship at Michigan State University. Dr. Rapson has served on the Michigan Society of Hematology and Oncology (MSHO) board of directors since 1996. She is also active in Michigan Oncology Quality Consortium (MOQC) and sits on the board of Its a Breast Thing in the Lansing area.

Dr. Rapson founded Red Cedar Oncology in East Lansing in 2012. She takes pride in her practice because it remains an independent practice with stellar employees who are as dedicated to providing quality patient care as she is. She loves sharing ideas with Dr. Anthony Brandau, who joined the practice five years ago and is as committed as she is to patients and the practice. Red Cedar Oncology strives to be at the top of innovation with new cutting-edge therapies that give more hope than ever to patients battling the disease. Dr. Rapson is excited by all the new drugs, interventions, clinical trials, and treatment options available for her patients and how well she sees them doing today with more clinical options available.

Dr. Rapson states that oncology and medicine have been a gift and very important part of her life. She believes that being an oncologist isn’t just a job; it is being able to have the true gift of devotion, dedication, and a supportive mentality towards your patients. 

Dr. Rapson and her husband, Tom, have been married for 45 years. They have two children and four grandchildren. They enjoy spending time on their horse farm with their family and animals. They enjoy vacationing in west Michigan in the summer and trips to Disneyland with their grandchildren.

Christopher M. Valley, ND, began practicing at Arthritis Northwest PLLC in Spokane, Washington, in 2011. 

Dr. Valley's approach combines conventional medicine with evidence-based natural medicine. His ability to select effective, safe options for patients with complex rheumatological conditions provides a welcome addition to the services available at Arthritis Northwest PLLC.

Dr. Valley graduated from Eastern Washington University in Cheney, Washington, with a bachelor’s degree in human biology. He initially intended to pursue a conventional medical degree. However, he changed his mind because of his keen interest in exercise science, clinical nutrition, and preventive medicine.

Dr. Valley attended the National College of Naturopathic Medicine in Portland, Oregon, which is the oldest naturopathic accredited medical school in the United States. He graduated in 2004 with a doctorate in naturopathic medicine.

Following his graduation, Dr. Valley practiced in family medicine for seven years, with a focus on sports medicine, inflammatory and autoimmune disorders, and endocrinology. 

As his interest in helping patients with arthritis grew, he made the move into specialist practice at Arthritis Northwest PLLC.

Christopher M. Valley, ND, began practicing at Arthritis Northwest PLLC in Spokane, Washington, in 2011. 

Dr. Valley's approach combines conventional medicine with evidence-based natural medicine. His ability to select effective, safe options for patients with complex rheumatological conditions provides a welcome addition to the services available at Arthritis Northwest PLLC.

Dr. Valley graduated from Eastern Washington University in Cheney, Washington, with a bachelor’s degree in human biology. He initially intended to pursue a conventional medical degree. However, he changed his mind because of his keen interest in exercise science, clinical nutrition, and preventive medicine.

Dr. Valley attended the National College of Naturopathic Medicine in Portland, Oregon, which is the oldest naturopathic accredited medical school in the United States. He graduated in 2004 with a doctorate in naturopathic medicine.

Following his graduation, Dr. Valley practiced in family medicine for seven years, with a focus on sports medicine, inflammatory and autoimmune disorders, and endocrinology. 

As his interest in helping patients with arthritis grew, he made the move into specialist practice at Arthritis Northwest PLLC.

Kamlesh Kumar Sankhala MD (also known as Dr. Kumar by his patients and colleagues) is a Medical Oncologist at Cedars-Sinai Medical Center in Los Angeles, California, and Director of Precision NextGen Oncology and Research Center, an independent center focused on treatment of complex, rare cancer and Sarcomas, as well as, clinical research in Oncology for expedited drug development and clinical research. Precision NextGen Oncology and Research Center  focuses on care for patients with Advanced Cancers who are refractory to conventional treatments. We provide care to these patients with multi- institutional coordinated care and access to novel and next generation therapies with or without clinical trials.

Dr. Sankhala specializes in clinical research and has pioneered a niche in treatments for patients with advanced and complex malignancies refractory to conventional treatments, along with rare cancer such as sarcomas.

Dr. Sankhala received his medical degree at the University of Rajasthan, India and undertook his internal medicine residency and fellowship training in oncology at the University of Texas Health Science Center. He had two years of additional fellowship in Oncology Drug Development at the University of Texas’s Institute for Drug Development. He was a clinical faculty at the University of Texas’s Health Science Center, and Clinical Investigator at the Institute for Drug Development (IDD). He also served as team leader for the University’s Sarcoma Program. Dr. Sankhala has served as the Co-Director, Sarcoma Medical Oncology and the Director of Clinical Research and Experimental Therapeutics Cedars-Sinai Medical Center’s THO.

Besides his Medical Oncology practice in advanced refractory cancers, Dr. Sankhala’s research focuses on translational research of novel anti-cancer agents and on studying the pre-clinical and clinical aspects of these agents. With an esteemed background in novel drug research and phase-1 clinical trials, Dr. Sankhala has evolved into a physician devoted to the translational research of novel anti-cancer agents by applying himself to the study and evaluation of pre-clinical and clinical implications of new agents in patients with advanced cancers. He has developed a clinical proficiency in using novel anticancer drugs for patients with advanced malignancies and has optimized existing chemotherapeutic agents by reducing toxicities and increasing efficacy, thereby yielding better responses to anti-cancer therapies. Dr. Sankhala's extensive clinical research background includes serving as the principal investigator and sub-investigator in more than 250 Phase-1 and other Oncology clinical trials.

Dr. Sankhala has served on advisory boards for many pharmaceutical companies to design, implicate, and conduct research on many novel oncology therapeutic molecules and has also helped several other companies to optimize and find the marketplace for novel therapies. He has also served as a member of Protocol Review and Management Committee (PRMC) and institutional review board (IRB) at Samuel Oschin Cancer Center at Cedars-Sinai Cancer Institute in Los Angeles.

Dr. Sankhala has been a reviewer of reputed journals in the field of Oncology such as the British Journal of Cancer, Cancer Chemotherapy & Pharmacology, Journal of Medical Case Report, Onkologie, and Bone Marrow Transplantation. He is an editorial board member for the Journal of Cancer Science, and Therapy and Chemotherapy.

Dr. Sankhala’s has authored and co-authored 71 numerous articles, and abstracts in journals including Journal of Clinical Oncology, Clinical Cancer Research, Oncology immunology, Investigational New Drugs, Cancer Journal, Expert Review in Hematology, Cancer chemotherapy and Pharmacology, JAMA Oncology, Clinical Breast Cancer, Cancer Chemotherapy Pharmacology, Molecular Cancer Therapeutics, Leukemia Lymphoma, Current Drug Target, Expert Opinion in Investigational Drugs, Future Oncology, Target Oncology, Expert opinion in Drug Metabolism and Toxicology, and Clinical Advancement in Hematology Oncology.

He is the recipient of the American Society of Clinical Oncology Foundation’s Merit Award and the AACR- NCI scholarship for Molecular Biology in Clinical Oncology. 

He has presented in many major national and international meetings including the American Society of Clinical Oncology (ASCO), Connective Tissue Oncology Society (CTOS), Japan’s Sarcoma Society, and many others. 

Beside Cedars-Sinai Medical Center, Dr. Sankhala has affiliations with various esteemed health facilities across Los Angeles, including Univversity of California at Los Angeles, University of Southern California and Providence Saint John's Health Center.

Dr. Sankhala’s academic interests extend to progressive fields including Healthcare Utilization Management, Managed Care, Consumer-Directed Healthcare, Healthcare Economics, and Medical Oncology Trend Management.

Cerebrum MD in Vienna, Virginia, was founded by board-certified neurosurgeon Joseph Watson, MD, and is dedicated to giving each patient access to innovative neurosurgical solutions. As specialists in neurological care, Dr. Watson and his team strive to provide truly personalized care and helping each patient understand and navigate their treatment options.

Patients choose Cerebrum MD when they need a skilled surgical team with extensive experience in brain tumors, pituitary tumors, and spinal tumors. They perform cerebral bypass surgery to restore blood flow to the brain when circulation is restricted due to a blocked artery. 

At Cerebrum MD, the team also successfully treats some of the most challenging conditions, such as brain aneurysms, trigeminal neuralgia, and brain and spine arteriovenous malformations. They also specialize in minimally invasive spinal surgery, safely treating problems such as spinal stenosis.

When patients need brain surgery, they can rely on comprehensive support from a team that understands the emotional challenges of making difficult decisions. From initial consultation and second opinions to surgery and post-operative care, every patient at Cerebrum MD receives respectful, informed attention and compassionate care.

To schedule an appointment or to find answers to difficult health conditions, call the office today.

Dr. Theodore K. Yang received his undergraduate degree at The University of Texas at Austin in physics and went on to work as a medical physicist before attending medical school. He received his medical degree and completed residency training in radiation oncology at The University of Texas Medical Branch at Galveston (UTMB).

He then joined the UTMB faculty specializing in head and neck therapy and brachytherapy. Board certified in therapeutic radiology, Dr. Yang has practiced radiation oncology Houston since 1984.

Dr. Yang is a member of professional medical societies, including the Harris County Medical Society, Texas Medical Association, American Medical Association, ASTRO (American Society for Therapeutic Radiology and Oncology) and CADAH (Chinese American Doctors Association of Houston). 

Dr. Theodore K. Yang received his undergraduate degree at The University of Texas at Austin in physics and went on to work as a medical physicist before attending medical school. He received his medical degree and completed residency training in radiation oncology at The University of Texas Medical Branch at Galveston (UTMB).

He then joined the UTMB faculty specializing in head and neck therapy and brachytherapy. Board certified in therapeutic radiology, Dr. Yang has practiced radiation oncology Houston since 1984.

Dr. Yang is a member of professional medical societies, including the Harris County Medical Society, Texas Medical Association, American Medical Association, ASTRO (American Society for Therapeutic Radiology and Oncology) and CADAH (Chinese American Doctors Association of Houston). 

Dr. Theodore K. Yang received his undergraduate degree at The University of Texas at Austin in physics and went on to work as a medical physicist before attending medical school. He received his medical degree and completed residency training in radiation oncology at The University of Texas Medical Branch at Galveston (UTMB).

He then joined the UTMB faculty specializing in head and neck therapy and brachytherapy. Board certified in therapeutic radiology, Dr. Yang has practiced radiation oncology Houston since 1984.

Dr. Yang is a member of professional medical societies, including the Harris County Medical Society, Texas Medical Association, American Medical Association, ASTRO (American Society for Therapeutic Radiology and Oncology) and CADAH (Chinese American Doctors Association of Houston). 

Nimi Tuamokumo, MD MPH graduated cum laude from Princeton University with a Bachelor of Arts degree in the Psychology. She received her M.D. from Yale University School of Medicine in New Haven, CT and her MPH degree from Harvard School of Public Health.

Dr. Tuamokumo completed an internship in the Department of Medicine at Mount Auburn Hospital in Cambridge, MA and a residency in Radiation Oncology at the Harvard Radiation Oncology Program. Dr. Tuamokumo specializes in Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT).

She is experienced in treating all types of malignancies. Dr. Tuamokumo has been with GHRO since completion of her residency in 2008. She has received many awards, including the National Institutes of Health Careers in Medicine Fellowship, American Cancer Society Outstanding Thesis Award, New England Cancer Society’s Daland Resident Award, NIH Cancer Education Grant, Etta S. Chidsey Award in Cancer Research.

Dr. Tuamokumo has published articles and given presentations on a range of topics including breast cancer, prostate cancer, pediatric cancer, and gastric cancer. She is a member of the Texas Medical Association, the American Society of Clinical Oncology, and the American Society for Therapeutic Radiology and Oncology. 

Nimi Tuamokumo, MD MPH graduated cum laude from Princeton University with a Bachelor of Arts degree in the Psychology. She received her M.D. from Yale University School of Medicine in New Haven, CT and her MPH degree from Harvard School of Public Health.

Dr. Tuamokumo completed an internship in the Department of Medicine at Mount Auburn Hospital in Cambridge, MA and a residency in Radiation Oncology at the Harvard Radiation Oncology Program. Dr. Tuamokumo specializes in Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT).

She is experienced in treating all types of malignancies. Dr. Tuamokumo has been with GHRO since completion of her residency in 2008. She has received many awards, including the National Institutes of Health Careers in Medicine Fellowship, American Cancer Society Outstanding Thesis Award, New England Cancer Society’s Daland Resident Award, NIH Cancer Education Grant, Etta S. Chidsey Award in Cancer Research.

Dr. Tuamokumo has published articles and given presentations on a range of topics including breast cancer, prostate cancer, pediatric cancer, and gastric cancer. She is a member of the Texas Medical Association, the American Society of Clinical Oncology, and the American Society for Therapeutic Radiology and Oncology. 

Nimi Tuamokumo, MD MPH graduated cum laude from Princeton University with a Bachelor of Arts degree in the Psychology. She received her M.D. from Yale University School of Medicine in New Haven, CT and her MPH degree from Harvard School of Public Health.

Dr. Tuamokumo completed an internship in the Department of Medicine at Mount Auburn Hospital in Cambridge, MA and a residency in Radiation Oncology at the Harvard Radiation Oncology Program. Dr. Tuamokumo specializes in Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT).

She is experienced in treating all types of malignancies. Dr. Tuamokumo has been with GHRO since completion of her residency in 2008. She has received many awards, including the National Institutes of Health Careers in Medicine Fellowship, American Cancer Society Outstanding Thesis Award, New England Cancer Society’s Daland Resident Award, NIH Cancer Education Grant, Etta S. Chidsey Award in Cancer Research.

Dr. Tuamokumo has published articles and given presentations on a range of topics including breast cancer, prostate cancer, pediatric cancer, and gastric cancer. She is a member of the Texas Medical Association, the American Society of Clinical Oncology, and the American Society for Therapeutic Radiology and Oncology. 

Patients at Golden Gate Cancer Center know they can take control of their cancer treatment at the radiation oncology practice in the SoMa (South of Market) neighborhood of San Francisco, California. Led by David Kornguth, MD, the chief of radiation oncology, the medical team and staff emphasize a patient-first philosophy based on respect and compassion, so patients make individualized choices regarding their health care and treatment. 

Golden Gate Cancer Center boasts above-average success rates thanks to its multidisciplinary approach for diagnosis, treatment, and coordinated care from the team of urologists, oncologists, radiation oncologists, and pathologists. 

Doctors and patients collaborate on treatment decisions, and those treatments are administered in a caring environment. Dr. Kornguth spends time with each patient, educating and recommending evidence-based treatments, while incorporating alternative and complementary medicine approaches for a non-conventional cancer treatment experience.

Because an individual’s health depends on their state of mind, diet, and activity level, patients enjoy a relaxing environment during appointments. 

The Golden Gate Cancer Center is fully equipped with technology and medical devices to provide a wide variety of radiotherapy and radiosurgery treatments, including intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), stereotactic body radiotherapy (SBRT), and stereotactic radiosurgery (SRS). 

In addition, the center offers Varian Halcyon™ treatments, Barrigel™ Hydrogel, and brachytherapy with VariSeed, also from Varian.

Learn more about the team at Golden Gate Cancer Center and schedule a consultation today by calling the office or using the online booking tool.

We have Chinese translation available in the center for our patients.  We use translation services for other languages.  

Premal Sanghavi, MD, FACS, is a board-certified, fellowship-trained oncoplastic breast surgeon practicing in downtown Los Angeles and Glendale, California. She completed her general surgery residency training from North Oakland Medical Centers/Wayne State University and breast surgery fellowship training in breast oncoplastic surgery at the University of Southern California in Los Angeles.

Dr. Sanghavi is a firm believer in patient-centered care. Her goal is to provide optimal patient care, minimizing the psychological and physical distress that’s caused when a woman is diagnosed with breast cancer.

Dr. Sanghavi’s scope of practice includes the treatment of both benign and malignant breast diseases. Surgeries performed include oncoplastic breast surgery, lumpectomy, mastectomy, intraoperative radiation therapy for breast cancer, sentinel lymph node biopsy, and excisional biopsies for benign lesions.

Her personal philosophy is “Always and only follow your heart, be strong and never give up!” Dr. Sanghavi welcomes new patients to Premal Sanghavi MD, Inc.

Premal Sanghavi, MD, FACS, is a board-certified, fellowship-trained oncoplastic breast surgeon practicing in downtown Los Angeles and Glendale, California. She completed her general surgery residency training from North Oakland Medical Centers/Wayne State University and breast surgery fellowship training in breast oncoplastic surgery at the University of Southern California in Los Angeles.

Dr. Sanghavi is a firm believer in patient-centered care. Her goal is to provide optimal patient care, minimizing the psychological and physical distress that’s caused when a woman is diagnosed with breast cancer.

Dr. Sanghavi’s scope of practice includes the treatment of both benign and malignant breast diseases. Surgeries performed include oncoplastic breast surgery, lumpectomy, mastectomy, intraoperative radiation therapy for breast cancer, sentinel lymph node biopsy, and excisional biopsies for benign lesions.

Her personal philosophy is “Always and only follow your heart, be strong and never give up!” Dr. Sanghavi welcomes new patients to Premal Sanghavi MD, Inc.

Steven Chen, MD, is a fellowship-trained oncologist surgeon who specializes in breast, endocrine, and melanoma surgery. Today, he is proud to work with the rest of the OasisMD team to help patients recover from the effects of cancer at OasisMD in Encinitas, San Diego, and Temecula, California. 

Dr. Chen completed both his undergraduate and medical degree at the University of Michigan in Ann Arbor, Michigan. He later performed his general surgery residency and critical care fellowship at the University of Michigan before moving to Los Angeles and completing a surgical oncology fellowship at the John Wayne Cancer Institute in Santa Monica, California.

Dr. Chen then joined the City of Hope, serving as the associate director of the Surgical Oncology Training Program. During his tenure there, Dr. Chen worked to train the next generation of surgical oncologists and served as the director of surgical oncology research. Dr. Chen also served as an associate professor of surgery. 

Throughout his career, Dr. Chen has also served as the chief of breast surgery and the chair of the Melanoma Tumor Board at the University of California, Davis Medical Center in Sacramento, California. His leadership ability led him to become a director of the American Society of Breast Surgeons and to assist in accrediting breast oncology training programs for the Society of Surgical Oncology. 

Dr. Chen has also held leadership positions in the American College of Surgeons, the American Medical Association, and the Association for Academic Surgery. A highly accomplished author, he has contributed to over 50 peer-reviewed medical publications, and he is often invited to deliver lectures all over the world. 

At OasisMD, Dr. Chen performs a variety of breast, thyroid, parathyroid, and melanoma procedures. He offers a wide range of oncology surgeries, including lumpectomy, mastectomy, and biopsy. Dr. Chen looks forward to continuing his work with cancer patients in the California area.

Steven Chen, MD, is a fellowship-trained oncologist surgeon who specializes in breast, endocrine, and melanoma surgery. Today, he is proud to work with the rest of the OasisMD team to help patients recover from the effects of cancer at OasisMD in Encinitas, San Diego, and Temecula, California. 

Dr. Chen completed both his undergraduate and medical degree at the University of Michigan in Ann Arbor, Michigan. He later performed his general surgery residency and critical care fellowship at the University of Michigan before moving to Los Angeles and completing a surgical oncology fellowship at the John Wayne Cancer Institute in Santa Monica, California.

Dr. Chen then joined the City of Hope, serving as the associate director of the Surgical Oncology Training Program. During his tenure there, Dr. Chen worked to train the next generation of surgical oncologists and served as the director of surgical oncology research. Dr. Chen also served as an associate professor of surgery. 

Throughout his career, Dr. Chen has also served as the chief of breast surgery and the chair of the Melanoma Tumor Board at the University of California, Davis Medical Center in Sacramento, California. His leadership ability led him to become a director of the American Society of Breast Surgeons and to assist in accrediting breast oncology training programs for the Society of Surgical Oncology. 

Dr. Chen has also held leadership positions in the American College of Surgeons, the American Medical Association, and the Association for Academic Surgery. A highly accomplished author, he has contributed to over 50 peer-reviewed medical publications, and he is often invited to deliver lectures all over the world. 

At OasisMD, Dr. Chen performs a variety of breast, thyroid, parathyroid, and melanoma procedures. He offers a wide range of oncology surgeries, including lumpectomy, mastectomy, and biopsy. Dr. Chen looks forward to continuing his work with cancer patients in the California area.

Joshua Kays, MD is a surgical oncologist on the team at Naab Road Surgical Group in Indianapolis with expertise in the treatment of gastrointestinal cancers and disorders. His clinical practice includes care of patients with primary and secondary liver tumors, bile duct cancer and disorders, gallbladder cancer and disorders, benign and malignant pancreatic tumors and disorders, stomach cancers, colon cancer, neuroendocrine tumors and sarcomas.  

Dr. Kays was raised in Hennepin, IL. He graduated from Northern Illinois University with a bachelor degree in cellular and molecular biology. He earned his medical degree from the University of Illinois-Peoria. Following medical school, Dr. Kays, moved to Indianapolis for general surgery residency at Indiana University. While a surgical resident he completed a two year oncology research fellowship and earned a master’s degree in translational research from Indiana University.  Upon completion of residency, Dr. Kays moved to Los Angeles where he completed a fellowship in complex general surgical oncology at Cedars-Sinai Medical Center.  Dr. Kays has authored numerous peer reviewed publications, presented at multiple regional and national meetings, and is a reviewer for the journal Surgical Endoscopy. 

Dr. Kays is a member of the American College of Surgeons, Society of Surgical Oncology, Americas Hepato-Pancreato-Biliary Association and American Society of Clinical Oncology. He continues to be active academically with his research focusing on liver, bile duct, gallbladder, pancreatic and gastric cancers and the muscle wasting syndrome known as cancer cachexia. Dr. Kays is a passionate and accomplished educator with multiple educational awards as a resident including the IU Department of Surgery Surgical Socrates Award as a chief resident. He continues to enjoy educating not only future surgeons and physicians, but also his patients and their families about their disease, surgery and treatments. 

When he is not serving his patients, Dr. Kays enjoys spending time with his wife and two daughters, archery and bow hunting, playing golf, attending sporting events, and traveling.

Omid S. Shaye, MD, is an oncologist and hematologist at Wellness Oncology and Hematology. Dr. Shaye treats patients at the practice’s medical offices in West Hills and Tarzana, California.

Dr. Shaye is a native of the San Fernando Valley. He earned his undergraduate degree from the University of Southern California in Los Angeles, then remained at USC to complete his Doctor of Medicine.

During his residency and fellowship in hematology and oncology at the USC Norris Cancer Center, Dr. Shaye was chosen as chief fellow of medical oncology. He then established Wellness Oncology and Hematology in order to share the newest, most cutting-edge therapeutic options with cancer and hematology patients in the San Fernando Valley.

Dr. Shaye sees his role as the “quarterback of a patient’s care,” offering individualized treatments that can include options like targeted therapies, clinical trials, immunotherapies, chemotherapy, radiation, and surgery. He spends time getting to know his patients and their families as he helps them along the road to wellness.

Dr. Shaye is certified by the American Board of Internal Medicine and the American Board of Medical Oncology. He is a member of the Medical Oncology Association of Southern California, the Community Oncology Alliance, and the American Society of Clinical Oncology. He speaks English, Spanish, and Farsi.